Use of aspirin associates with longer primary patency of hemodialysis grafts.

Dixon BS, Beck GJ, Dember LM, Vazquez MA, Greenberg A, Delmez JA, Allon M, Himmelfarb J, Hu B, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Lawson JH, Cotton JR, Kusek JW, Feldman HI, Dialysis Access Consortium (DAC) Study Group
J Am Soc Nephrol. 2011 22 (4): 773-81

PMID: 21415156 · PMCID: PMC3065232 · DOI:10.1681/ASN.2010060582

MeSH Terms (21)

Adult Aged Arteriovenous Shunt, Surgical Aspirin Aspirin, Dipyridamole Drug Combination Chronic Disease Dipyridamole Drug Combinations Drug Therapy, Combination Female Follow-Up Studies Humans Kidney Diseases Male Middle Aged Platelet Aggregation Inhibitors Proportional Hazards Models Renal Dialysis Thrombosis Treatment Outcome Vascular Patency

Connections (1)

This publication is referenced by other Labnodes entities:

Links